id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-P-7432-0006,FDA,FDA-2025-P-7432,Completeness Assessment Correspondence,Other,Assessment Document or Analysis,2026-01-20T05:00:00Z,2026,1,2026-01-20T05:00:00Z,,2026-01-20T21:15:24Z,,0,0,09000064b9161b92
FDA-2025-P-7432-0001,FDA,FDA-2025-P-7432,"Suitability Petition from Hyman, Phelps & McNamara, P.C.",Other,Petition(s),2025-12-31T05:00:00Z,2025,12,2025-12-31T05:00:00Z,,2025-12-31T21:53:55Z,,1,0,09000064b9114959
FDA-2025-P-7432-0002,FDA,FDA-2025-P-7432,"Acknowledgement Letter from FDA DMB to Hyman, Phelps & McNamara, P.C.",Other,Acknowledgement Letter/Receipt,2025-12-31T05:00:00Z,2025,12,2025-12-31T05:00:00Z,,2025-12-31T21:56:20Z,,0,0,09000064b911495a
FDA-2025-P-7432-0004,FDA,FDA-2025-P-7432,Attachment 2,Supporting & Related Material,Background Material,2025-12-31T05:00:00Z,2025,12,,,2025-12-31T21:56:46Z,,0,0,09000064b91145e8
FDA-2025-P-7432-0005,FDA,FDA-2025-P-7432,Attachment 3,Supporting & Related Material,Background Material,2025-12-31T05:00:00Z,2025,12,,,2025-12-31T21:56:48Z,,0,0,09000064b91145e9
FDA-2025-P-7432-0003,FDA,FDA-2025-P-7432,Attachment 1,Supporting & Related Material,Background Material,2025-12-31T05:00:00Z,2025,12,,,2025-12-31T21:56:44Z,,0,0,09000064b91145e7